Heron Therapeutics, Inc. Profile Avatar - Palmy Investing

Heron Therapeutics, Inc.

Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a …

Biotechnology
US, San Diego [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

Not a single 10-Q doc.

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of HRTX's Analysis
CIK: 818033 CUSIP: 427746102 ISIN: US4277461020 LEI: - UEI: -
Secondary Listings
HRTX has no secondary listings inside our databases.